The US Food and Drug Administration's proposed major reorganization for departmental review includes a change stripping complaint-handling responsibilities from the agency’s field organization, the Office of Regulatory Affairs.
Sparked by a lost whistleblower complaint about infant formula manufacturing, the revamping of the FDA's Human Foods Program and field operation makes both the food program and the agency’s product centers – such as the Center for Drug Evaluation and Research and the Center for Food Safety and
Rogers To Lead ORA
The FDA also appointed Michael Rogers as associate commissioner for regulatory affairs. Rogers, who has worked 32 years at the agency including 28 in the ORA, had been acting associate commissioner since September, when ORA’s previous acting associate commissioner, Carol Cave, retired
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?